Significantly altered systemic exposure to atorvastatin acid following gastric bypass surgery in morbidly obese patients (original) (raw)

Long-term effects of gastric bypass and duodenal switch on systemic exposure of atorvastatin

Surgical Endoscopy

The effects of gastric bypass surgery on drug absorption and pharmacokinetics

Impact of body weight, low energy diet and gastric bypass on drug bioavailability, cardiovascular risk factors and metabolic biomarkers: protocol for an open, non-randomised, three-armed single centre study (COCKTAIL)

Rune Sandbu

BMJ Open, 2018

View PDFchevron_right

The effect of atorvastatin on heart rate variability and lipoproteins in patients treated with coronary bypass surgery

Erik Schmidt, Egon Toft

International Journal of Cardiology, 2006

View PDFchevron_right

Effects of atorvastatin on arterial endothelial function in coronary bypass surgery

Germano Sciascio

European Journal of Cardio-Thoracic Surgery, 2005

View PDFchevron_right

Assessment of Atorvastatin Effect on Body Weight and Blood Glucose Levels Among Diabetic and Non-Diabetic Patients

Nahla Al-bayyari

Romanian Journal of Diabetes Nutrition and Metabolic Diseases, 2017

View PDFchevron_right

Evaluation of an In Silico PBPK Post-Bariatric Surgery Model through Simulating Oral Drug Bioavailability of Atorvastatin and Cyclosporine

Adam S Darwich

CPT: pharmacometrics & systems pharmacology, 2013

View PDFchevron_right

Improved Levothyroxine Pharmacokinetics After Bariatric Surgery

George Markantes

View PDFchevron_right

Circulating concentrations of high-molecular-weight adiponectin are increased following Roux-en-Y gastric bypass surgery

Mohamed Ali, Marta Van Loan

Diabetologia, 2006

View PDFchevron_right

Intensive Lipid-Lowering With Atorvastatin for Secondary Prevention in Patients After Coronary Artery Bypass Surgery

Andrei Breazna, David Waters

Journal of the American College of Cardiology, 2008

View PDFchevron_right

Medication and nutritional supplement use before and after bariatric surgery

Edyane Lopes

Sao Paulo Medical Journal, 2016

View PDFchevron_right

Oral drug dosing following bariatric surgery: General concepts and specific dosing advice

Catherine M T Sherwin

British Journal of Clinical Pharmacology, 2021

View PDFchevron_right

Failure to recapture cardioprotection with high-dose atorvastatin in coronary artery bypass surgery: a randomised controlled trial

John Yap

Basic Research in Cardiology, 2011

View PDFchevron_right

Feasibility Of A Prospective Longitudinal Mechanistic Clinical Trial Aiming To Examine The Effects Of Gastric Bypass Surgery On Intestinal Metabolism (Preprint)

Anita Courcoulas

JMIR Research Protocols

View PDFchevron_right

Review article: The nutritional and pharmacological consequences of obesity surgery

Rudolf Weiner

Alimentary pharmacology & therapeutics, 2014

View PDFchevron_right

Haematological parameters and serum trace elements in “healthy” and “unhealthy” morbidly obese patients before and after gastric bypass

Enric Caubet

Clinical Nutrition, 2015

View PDFchevron_right

Effect of Gastric Bypass Surgery on the Absorption and Bioavailability of Metformin

Raj Padwal

Diabetes …, 2011

View PDFchevron_right

Reduced Cardiovascular Risk Following Bariatric Surgeries is Related to a Partial Recovery from “Adiposopathy”

Manjula Gupta

Obesity Surgery, 2011

View PDFchevron_right

Trends in oral drug bioavailability following bariatric surgery: examining the variable extent of impact on exposure of different drug classes

Adam S Darwich

British Journal of Clinical Pharmacology, 2012

View PDFchevron_right

The influence of bariatric surgery on oral drug bioavailability in patients with obesity: A systematic review

Rune Sandbu

Obesity Reviews

View PDFchevron_right

Effect of atorvastatin on postprandial lipoprotein metabolism in hypertriglyceridemic patients

Ron Barrett

The Journal of Lipid Research, 2003

View PDFchevron_right

The Effects of Atorvastatin Consumption on Biochemical Variables in Patients with Type 2 Diabetes Mellitus and Pre-diabetes

Karimollah Hajian-Tilaki

International Journal of Medical Laboratory

View PDFchevron_right

Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial

Bruno Caramelli

Journal of Vascular Surgery, 2004

View PDFchevron_right

Preoperative weight gain might increase risk of gastric bypass surgery

Donald Hess

Surgery for Obesity and Related Diseases, 2011

View PDFchevron_right

Adipokine Response in Diabetics and Nondiabetics Following the Roux-en-Y Gastric Bypass: A Preliminary Study

Henry Buchwald

Journal of Surgical Research, 2007

View PDFchevron_right

Impacts of Different Modes of Bariatric Surgery on Plasma Levels of Hepassocin in Patients with Diabetes Mellitus

Wei-Jei Lee

Reports, 2019

View PDFchevron_right

Metabolic adaptation following gastric bypass surgery: Results from a 2-year observational study

Ruth Price

2024

View PDFchevron_right

Increase of the Adiponectin/Leptin Ratio in Patients with Obesity and Type 2 Diabetes after Roux-en-Y Gastric Bypass

Javier Salvador

Nutrients, 2019

View PDFchevron_right

Acute and chronic effect of bariatric surgery on circulating autotaxin levels

Simon Marceau

Physiological Reports, 2019

View PDFchevron_right

The safety and tolerability of atorvastatin 10 mg in the Collaborative Atorvastatin Diabetes Study (CARDS)

Andrew Neil

Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease, 2008

View PDFchevron_right

Significantly altered systemic exposure to atorvastatin acid following gastric bypass surgery in morbidly obese patients (original) (raw)

Related papers